Dry Needling & Trigger Point Compression Release in Neck Pain

NCT ID: NCT05870904

Last Updated: 2023-05-23

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 30 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2021-06-01
• Study Completion Date: 2021-10-31

Brief Summary

This randomized control trial was conducted to investigate the efficacy of trigger point dry needling which is a modern treatment intervention compared with ischemic compression release in the patients having neck pain due to myofascial trigger points.

Detailed Description

Many treatment protocols have been used in the clinical arena for the improvement of neck pain but un-availability of follow-up studies and lack of evidence of modern treatment interventions are few shortcomings a researcher faces. Thus, a need stands up to address these perspectives for newer treatment strategies. This randomized control trial is conducted to investigate the efficacy of trigger point dry needling which is a modern treatment intervention compared with ischemic compression release in the patients having neck pain due to myofascial trigger points. Findings of this research will assist in creating awareness about better treatment intervention for trigger point release among medical community.

Conditions

Neck Pain; Trigger Point Pain, Myofascial; Neck Muscle Issue; Muscle Tightness; Neckache

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: TREATMENT
• Blinding Strategy: SINGLE

Study Groups

Dry Needling Group

Received dry needling through the insertion of fusiform needle for the trigger point release on 3 days a week aimed at pain relief.

Group Type: EXPERIMENTAL

Dry Needling

Intervention Type: OTHER

Dry Needling includes the insertion of a fine, strong filiform needle without presentation of any pain relieving medicine.

Ischemic pressure is usually applied to trigger point, in what is known as trigger point therapy, where enough continuous pressure is applied to a trigger point within a tolerable measure of pain, and as discomfort is decreased, extra pressure is gradually applied

Ischemic Compression Group

Received ischemic compression release through thumb pressure for trigger points on 3 days a week.

Group Type: ACTIVE_COMPARATOR

Dry Needling

Intervention Type: OTHER

Dry Needling includes the insertion of a fine, strong filiform needle without presentation of any pain relieving medicine.

Ischemic pressure is usually applied to trigger point, in what is known as trigger point therapy, where enough continuous pressure is applied to a trigger point within a tolerable measure of pain, and as discomfort is decreased, extra pressure is gradually applied

Interventions

Dry Needling

Dry Needling includes the insertion of a fine, strong filiform needle without presentation of any pain relieving medicine.

Ischemic pressure is usually applied to trigger point, in what is known as trigger point therapy, where enough continuous pressure is applied to a trigger point within a tolerable measure of pain, and as discomfort is decreased, extra pressure is gradually applied

Intervention Type: OTHER

Other Intervention Names

Ischemic Compression

Eligibility Criteria

Inclusion Criteria

• Patients between the age group of 20 to 40 years.
• Both Male and female patients.
• Patients presenting with neck pain due to MTrP's.
• The presence of a palpable taut band in the neck region.
• Patients reporting typically referred pain pattern of the MTrP in response to compression.

Exclusion Criteria

• Patients with any associated comorbidities such as hypertension and diabetes.
• Patients with known history of fibromyalgia syndrome, whiplash injury, cervical spine surgery fracture and cervical radiculopathy.
• Patients with any systemic disease such as rheumatism and tuberculosis or cervical myelopathy and multiple sclerosis.
• Patients with history of myofascial trigger point therapy one month prior to enrollment.
• Patients with non-cooperative attitude, fear or any contraindications to needling.

• Minimum Eligible Age: 20 Years
• Maximum Eligible Age: 40 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Health Education Research Foundation (HERF)

OTHER

Sponsor Role: lead

Responsible Party

Mamoona Tasleem Afzal

Senior Lecturer

Responsibility Role: PRINCIPAL_INVESTIGATOR

Locations

Bashir Institute of Health Sciences,Bashir General & Dental Hospital

Islamabad, , Pakistan

Countries

Pakistan

Other Identifiers

070/BPMI/ Saad Tariq DPT

Identifier Type: -

Identifier Source: org_study_id